Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...
Occasionally, the swelling of the submaxillary glands precedes that of the parotid. In rare cases they even remain the only glands affected. It was suggested that in these cases the urinary ...
[7,8] More than 400 drugs, some in common use, can cause oral dryness and induce salivary gland hypofunction. [9] Xerogenic medications include anticholinergic drugs, anorectics, antihistamines ...
OBJECTIVES To investigate the safety and efficacy of ultrasound guided botulinum toxin type A (BTX-A) injections into salivary glands for the treatment of sialorrhoea in patients with neurological ...